This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gravholt, C. H. Articles by Schmitz, O. Search for Related Content PubMed PubMed Citation Articles by Gravholt, C. H. Articles by Schmitz, O.

Physiological Levels of Glucagon Do Not Influence Lipolysis in Abdominal Adipose Tissue as Assessed by Microdialysis¹

Department of Endocrinology M and Medical Research Laboratories (C.H.G., N.M., J.S.C., O.S.), Århus University Hospital, DK-8000 Århus C, Denmark; and Endocrine Research Unit (M.D.J.), Mayo Clinic, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: Claus Højbjerg Gravholt, M.D., Department of Endocrinology M, Århus Kommunehospital, Århus University Hospital, DK-8000 Århus C, Denmark. E-mail: ch.gravholt{at}dadlnet.dk

To determine whether glucagon stimulates lipolysis in adipose tissue, seven healthy young male volunteers were studied, with indwelling microdialysis catheters placed sc in abdominal adipose tissue. Subjects were studied three times: 1) during euglucagonemia (EG; glucagon infusion rate, 0.5 ng/kg·min); 2) during hyperglucagonemia (HG; (glucagon infusion rate, 1.5 ng/kg·min); and 3) during EG and a concomitant glucose infusion mimicking the glucose profile from the day of HG (EG+G). Somatostatin (450 µg/h) was infused to suppress hormonal secretion, and replacement doses of insulin and GH were administered. Sampling was done every 30 min for 420 min. Baseline circulating values of insulin, C-peptide, glucagon, GH, glycerol, and free fatty acids were comparable in all three conditions. During EG and EG+G, plasma glucagon was maintained at fasting level (20–40 ng/L); whereas, during HG, it increased (110–130 ng/L). Interstitial concentrations of glycerol were similar in the three conditions [30,870 ± 5,946 (EG) vs. 31,074 ± 7,092 (HG) vs. 29,451 ± 6,217 (EG+G) µmol/L·120 min, P = 0.98]. Plasma glycerol (ANOVA, P = 0.5) and free fatty acids (ANOVA, P = 0.3) were comparable during the different glucagon challenges. We conclude that HG per se does not increase interstitial glycerol (and thus lipolysis) in abdominal sc adipose tissue; nor does modest hyperglycemia, during basal insulinemia and glucagonemia, influence indices of abdominal sc lipolysis.

This article has been cited by other articles:

				I. Quesada, E. Tuduri, C. Ripoll, and A. Nadal Physiology of the pancreatic {alpha}-cell and glucagon secretion: role in glucose homeostasis and diabetes J. Endocrinol., October 1, 2008; 199(1): 5 - 19. [Abstract] [Full Text] [PDF]

				P. Brassard, F. Frisch, F. Lavoie, D. Cyr, A. Bourbonnais, S. C. Cunnane, B. W. Patterson, R. Drouin, J.-P. Baillargeon, and A. C. Carpentier Impaired Plasma Nonesterified Fatty Acid Tolerance Is an Early Defect in the Natural History of Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 837 - 844. [Abstract] [Full Text] [PDF]

				N. Rivera, C. A. Everett-Grueter, D. S. Edgerton, T. Rodewald, D. W. Neal, E. Nishimura, M. O. Larsen, L. O. Jacobsen, K. Kristensen, C. L. Brand, et al. A Novel Glucagon Receptor Antagonist, NNC 25-0926, Blunts Hepatic Glucose Production in the Conscious Dog J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 743 - 752. [Abstract] [Full Text] [PDF]

				A. C. Carpentier, F. Frisch, P. Brassard, F. Lavoie, A. Bourbonnais, D. Cyr, R. Giguere, and J.-P. Baillargeon Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E693 - E701. [Abstract] [Full Text] [PDF]

				G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, D. B. Panagiotakos, E. Koukkou, M. Tzanela, N. Thalassinos, and S. A. Raptis Insulin Action in Adipose Tissue and Muscle in Hypothyroidism J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4930 - 4937. [Abstract] [Full Text] [PDF]

				A. C. Carpentier, F. Frisch, D. Cyr, P. Genereux, B. W. Patterson, R. Giguere, and J.-P. Baillargeon On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E849 - E856. [Abstract] [Full Text] [PDF]

				J. K. Nielsen, C. B. Djurhuus, C. H. Gravholt, A. C. Carus, J. Granild-Jensen, H. Orskov, and J. S. Christiansen Continuous Glucose Monitoring in Interstitial Subcutaneous Adipose Tissue and Skeletal Muscle Reflects Excursions in Cerebral Cortex Diabetes, June 1, 2005; 54(6): 1635 - 1639. [Abstract] [Full Text] [PDF]

				J. J. Christiansen, C. H. Gravholt, S. Fisker, N. Moller, M. Andersen, B. Svenstrup, P. Bennett, P. Ivarsen, J. S. Christiansen, and J. O. L. Jorgensen Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism Eur. J. Endocrinol., January 1, 2005; 152(1): 77 - 85. [Abstract] [Full Text] [PDF]

				S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, E. P. Donahue, P. Flakoll, and A. D. Cherrington Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E695 - E707. [Abstract] [Full Text] [PDF]

				C. B. Djurhuus, C. H. Gravholt, S. Nielsen, A. Mengel, J. S. Christiansen, O. E. Schmitz, and N. Moller Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E172 - E177. [Abstract] [Full Text] [PDF]